Home NDC 59011-444 DILAUDID
Product NDC 59011-444
11-digit product format 590110444
Labeler code 59011
Product ID 59011-444_182d5b8e-6145-60ab-a2ec-a188aa83eb98
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name HYDROMORPHONE HYDROCHLORIDE
Dosage form INJECTION, SOLUTION
Route INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Labeler Purdue Pharma LP
Application NDA019034
Marketing category NDA
Marketing start 1926-01-01
Marketing end 0000-00-00
Substance HYDROMORPHONE HYDROCHLORIDE
Active strength 4 mg/mL
Pharmacologic classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]
DEA schedule CII
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 59011-444-10 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 59011-444-10 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 59011-444-10 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 59011-444-10 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 59011-444-10 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 59011-444-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 59011-444-10 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 59011-444-10 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 59011-444-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 59011-444-10 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 59011-444-10 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 59011-444-10 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 59011-444-10 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 59011-444-10 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 59011-444-10 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 59011-444-10 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 59011-444-10 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 59011-444-10 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N019034-001 DILAUDID-HP HYDROMORPHONE HYDROCHLORIDE 10MG/ML INJECTABLE / INJECTION AP RLD, RS 1984-01-11 N019034-002 DILAUDID-HP HYDROMORPHONE HYDROCHLORIDE 250MG/VIAL INJECTABLE / INJECTION 1994-08-04 N019034-003 DILAUDID HYDROMORPHONE HYDROCHLORIDE 1MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 N019034-004 DILAUDID HYDROMORPHONE HYDROCHLORIDE 2MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 N019034-005 DILAUDID HYDROMORPHONE HYDROCHLORIDE 4MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 N019034-006 DILAUDID HYDROMORPHONE HYDROCHLORIDE 0.2MG/ML INJECTABLE / INJECTION AP RLD, RS 2020-01-16 N019034-007 DILAUDID HYDROMORPHONE HYDROCHLORIDE 0.5MG/0.5ML INJECTABLE / INJECTION AP RLD, RS 2017-02-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Orange Book patents# Current patent rows page 1 of 1 · 14 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N019034-001 9731082 2032-04-23 Drug product 2018-02-05 N019034-001 9248229 2034-03-12 Drug product 2018-02-05 N019034-002 9731082 2032-04-23 Drug product 2018-02-05 N019034-002 9248229 2034-03-12 Drug product 2018-02-05 N019034-003 9731082 2032-04-23 Drug product 2018-02-05 N019034-003 9248229 2034-03-12 Drug product 2018-02-05 N019034-004 9731082 2032-04-23 Drug product 2018-02-05 N019034-004 9248229 2034-03-12 Drug product 2018-02-05 N019034-005 9731082 2032-04-23 Drug product 2018-02-05 N019034-005 9248229 2034-03-12 Drug product 2018-02-05 N019034-006 9731082 2032-04-23 Drug product 2023-05-23 N019034-006 9248229 2034-03-12 Drug product 2023-05-23 N019034-007 9731082 2032-04-23 Drug product 2018-02-05 N019034-007 9248229 2034-03-12 Drug product 2018-02-05
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 7 · 259 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N019034-001 DILAUDID-HP 10MG/ML INJECTABLE / INJECTION RLD 1984-01-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-002 DILAUDID-HP 250MG/VIAL INJECTABLE / INJECTION 1994-08-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-003 DILAUDID 1MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-004 DILAUDID 2MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-005 DILAUDID 4MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-006 DILAUDID 0.2MG/ML INJECTABLE / INJECTION AP RLD, RS 2020-01-16 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-007 DILAUDID 0.5MG/0.5ML INJECTABLE / INJECTION AP RLD, RS 2017-02-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-001 DILAUDID-HP 10MG/ML INJECTABLE / INJECTION RLD 1984-01-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-002 DILAUDID-HP 250MG/VIAL INJECTABLE / INJECTION 1994-08-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-003 DILAUDID 1MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-004 DILAUDID 2MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-005 DILAUDID 4MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-006 DILAUDID 0.2MG/ML INJECTABLE / INJECTION AP RLD, RS 2020-01-16 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-007 DILAUDID 0.5MG/0.5ML INJECTABLE / INJECTION AP RLD, RS 2017-02-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N019034-001 DILAUDID-HP 10MG/ML INJECTABLE / INJECTION RLD 1984-01-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-002 DILAUDID-HP 250MG/VIAL INJECTABLE / INJECTION 1994-08-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-003 DILAUDID 1MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-004 DILAUDID 2MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-005 DILAUDID 4MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-006 DILAUDID 0.2MG/ML INJECTABLE / INJECTION AP RLD, RS 2020-01-16 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-007 DILAUDID 0.5MG/0.5ML INJECTABLE / INJECTION AP RLD, RS 2017-02-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019034-001 DILAUDID-HP 10MG/ML INJECTABLE / INJECTION RLD 1984-01-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019034-002 DILAUDID-HP 250MG/VIAL INJECTABLE / INJECTION 1994-08-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019034-003 DILAUDID 1MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019034-004 DILAUDID 2MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019034-005 DILAUDID 4MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019034-006 DILAUDID 0.2MG/ML INJECTABLE / INJECTION AP RLD, RS 2020-01-16 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N019034-007 DILAUDID 0.5MG/0.5ML INJECTABLE / INJECTION AP RLD, RS 2017-02-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019034-001 DILAUDID-HP 10MG/ML INJECTABLE / INJECTION RLD 1984-01-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019034-002 DILAUDID-HP 250MG/VIAL INJECTABLE / INJECTION 1994-08-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019034-003 DILAUDID 1MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019034-004 DILAUDID 2MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019034-005 DILAUDID 4MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019034-006 DILAUDID 0.2MG/ML INJECTABLE / INJECTION AP RLD, RS 2020-01-16 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N019034-007 DILAUDID 0.5MG/0.5ML INJECTABLE / INJECTION AP RLD, RS 2017-02-10 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019034-001 DILAUDID-HP 10MG/ML INJECTABLE / INJECTION RLD 1984-01-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019034-002 DILAUDID-HP 250MG/VIAL INJECTABLE / INJECTION 1994-08-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019034-003 DILAUDID 1MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019034-004 DILAUDID 2MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N019034-005 DILAUDID 4MG/ML INJECTABLE / INJECTION AP RLD, RS 2009-04-30 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 124 observed states.
Observed Orange Book patent history# Patent history page 1 of 13 · 518 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N019034-001 9731082 2032-04-23 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-001 9248229 2034-03-12 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-002 9731082 2032-04-23 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-002 9248229 2034-03-12 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-003 9731082 2032-04-23 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-003 9248229 2034-03-12 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-004 9731082 2032-04-23 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-004 9248229 2034-03-12 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-005 9731082 2032-04-23 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-005 9248229 2034-03-12 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-006 9731082 2032-04-23 Drug product 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-006 9248229 2034-03-12 Drug product 2023-05-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-007 9731082 2032-04-23 Drug product 2018-02-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N019034-007 9248229 2034-03-12 Drug product 2018-02-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-001 9731082 2032-04-23 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-001 9248229 2034-03-12 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-002 9731082 2032-04-23 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-002 9248229 2034-03-12 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-003 9731082 2032-04-23 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-003 9248229 2034-03-12 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-004 9731082 2032-04-23 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-004 9248229 2034-03-12 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-005 9731082 2032-04-23 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-005 9248229 2034-03-12 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-006 9731082 2032-04-23 Drug product 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-006 9248229 2034-03-12 Drug product 2023-05-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-007 9731082 2032-04-23 Drug product 2018-02-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N019034-007 9248229 2034-03-12 Drug product 2018-02-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N019034-001 9731082 2032-04-23 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-001 9248229 2034-03-12 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-002 9731082 2032-04-23 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-002 9248229 2034-03-12 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-003 9731082 2032-04-23 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-003 9248229 2034-03-12 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-004 9731082 2032-04-23 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-004 9248229 2034-03-12 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-005 9731082 2032-04-23 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-005 9248229 2034-03-12 Drug product 2018-02-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-006 9731082 2032-04-23 Drug product 2023-05-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N019034-006 9248229 2034-03-12 Drug product 2023-05-23 6a471c1ec25d…
FDA-Initiated Inactive NDC Indexing# NDC, Effective, Action table NDC Effective Action Document Indexing SPL Related label 59011-444-10 2022-07-21 C162847 48780-1 9d75b9d0-188e-f424-e053-dadaa90a57ce These highlights do not include all the information needed to use DILAUDID ® INJECTION and DILAUDID-HP ® INJECTION safely and effectively. See full prescribing information for DILAUDID® INJECTION and DILAUDID-HP ® INJECTION. DILAUDID ® INJECTION (hydromorphone hydrochloride) and DILAUDID-HP ® INJECTION (hydromorphone hydrochloride), for intravenous, intramuscular, or subcutaneous use, CII Initial U.S. Approval: January 1984 59011-444-10 2020-01-31 C162847 48780-1 9d75b9d0-188e-f424-e053-dadaa90a57ce These highlights do not include all the information needed to use DILAUDID ® INJECTION and DILAUDID-HP ® INJECTION safely and effectively. See full prescribing information for DILAUDID® INJECTION and DILAUDID-HP ® INJECTION. DILAUDID ® INJECTION (hydromorphone hydrochloride) and DILAUDID-HP ® INJECTION (hydromorphone hydrochloride), for intravenous, intramuscular, or subcutaneous use, CII Initial U.S. Approval: January 1984
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded hydromorphone hydrochloride ACTIVE INGREDIENT L960UP2KRW DILAUDID (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PURDUE PHARMA LP] 9 hydromorphone ACTIVE MOIETY Q812464R06 DILAUDID (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PURDUE PHARMA LP] 9 citric acid monohydrate INACTIVE INGREDIENT 2968PHW8QP DILAUDID (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PURDUE PHARMA LP] 9 hydrochloric acid INACTIVE INGREDIENT QTT17582CB DILAUDID (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PURDUE PHARMA LP] 9 sodium citrate INACTIVE INGREDIENT 1Q73Q2JULR DILAUDID (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PURDUE PHARMA LP] 9 sodium hydroxide INACTIVE INGREDIENT 55X04QC32I DILAUDID (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PURDUE PHARMA LP] 9 water INACTIVE INGREDIENT 059QF0KO0R DILAUDID (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, SOLUTION DILAUDID HP (HYDROMORPHONE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PURDUE PHARMA LP] 9
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.